Chang CH, Hsiao CF, Chang GC, Tsai YH, Chen YM, Huang MS, Su WC, Hsieh WS, Yang PC, Chen CJ, Hsiung CA*, 2009, “Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan”, Am J Epidemiol, 170(6), 695-702. (SCI)
Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ, Hsiung CA*, 2009, “A polymorphism in the APE1 gene promoter is associated with lung cancer risk”, Cancer Epidemiol Biomarkers Prev, 18, 223-229.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group Schulz TF, Mueller N, Grulich A, Sitas F, Polman K, Chen CJ, Fang YY, Herrero R, Vennervald BJ, Mahieux R, Mégraud F, Zoulim F, Blum H, zur Hausen H, Banks L, Carbone A, Serraino D, Matsuoka M, Hong ST, Kew MC, de Sanjosé S, Ernberg I, Sripa B, Hall A, Forman D, Newton R, Cesarman E, Dittmer D, Fontham ET, Lambert PF, Moss S, Murphy E, Schiffman M, Stuver S, Whitby D, 2009, “A review of human carcinogens-Part B: biological agents”, Lancet Oncol, 10:321-322. (SCI)
Wang YH, Yeh SD, Shen KH, Shen CH, Juang GD, Hsu LI, Chiou HY*, Chen CJ, 2009, “A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. ”, Toxicol Appl Pharmacol, 241(1):111-8. (SCI)
H. C. Wu, Q. Wang, H. I. Yang, H. Ahsan, W. Y. Tsai,L. Y. Wang, S. Y. Chen, C. J. Chen and R. M. Santella*, 2009, “Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan”, Cancer Epidemiol Biomarkers Prev, 18, 846-853.
Huang SK, Chiu AW, Pu YS, Huang YK, Chung CJ, Tsai HJ, Yang MH, Chen CJ, Hsueh YM, 2009, “Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma”, Urol Int, 82,227-234. (SCI)
Jou YS, Lo YL, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen YM, Huang MS, Chen HL, Chen CJ, Yang PC, Hsiung CA*, 2009, “Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients”, Lung Cancer, 64:251-256.
Yu KJ, Gao X, Chen CJ, Yang XR, Diehl SR, Goldstein A, Hsu WL, Liang XS, Marti D, Liu MY, Chen JY, Carrington M, Hildesheim A*, 2009, “Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan ”, Hum Immunol, 70(11):910-4. (SCI)
Huang LC, Chen SC, Tjung JJ, Chiou HY*, Chen CJ, Tsai CH, 2009, “Body mass index as a predictor of mortality in older people in Taiwan (1982-2005)”, Int J Gerontol, 3:39-46. (SCI)
Yu KJ, Hsu WL, Chiang CJ, Cheng YJ, Pfeiffer RM, Diehl SR, Goldstein AM Gravitt PE, Chen CJ, Hildesheim A*., 2009, “Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan.”, Int J Cancer, 124:1622-1625. (SCI)
Huang YK, Huang YL, Hsueh YM*, Wang JT, Yang MH, Chen CJ, 2009, “Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan.”, Environ Health Persepct, 117, 1860-1866.
Cheng WF, Huang CY, You SL, Chen CJ, Hu CH, Chen CA*, 2009, “Clinical significance of cytologic atypical squamous cells of undetermined significance”, Obstetr Gynecol, 113:888-894.
Chen CH, Chiou HY, Hsueh YM, Chen CJ, Yu HJ, Pu YS*, 2009, “Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan”, J Urol, 181, 547-552.
Chang MH*, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS, the Taiwan Hepatoma Study Group, 2009, “Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study”, J Natl Cancer Inst, 101(19), 1348-1355.
Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ*, 2009, “Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experience”, Br J Cancer, 101, 174-177.
Chen CJ, 2009, “Environmental health issues in public health”, editor(s): Detels R, Beaglehole R, Lansang MA, Gulliford M, Oxford Textbook of Public Health, Fifth Edition, pp. 825-840, Oxford: Oxford University Press.
Tsai MY, Lin LL, Lee V, Chen CJ, Shih YF , 2009, “Estimation of heritability in myopic twin studies”, Jpn J Ophtalmol, 53:615-622.
Su TC, Hwang LC, You SL, Chen CJ*, 2009, “Ethnic variation in hypertension prevalence of women in Taiwan”, J Human Hypertens, 23, 160-167.
Chen CF, Yang HI, Chang HC, Chen CJ, 2009, “Gender difference in hepatocellular carcinoma associated with chronic hepatitis B and C”, editor(s): Shimizu I, Female Hepatology, pp. 1-20, Kerala: Research Signpost.
Su WW, Chen CH, Lin HH, Yang SS, Chang TT, Cheng KS, Wu JC, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN, 2009, “Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas ”, Hepatol Int, 3:537-543. (SCI)
Chen CJ*, Yang HI, Ioleje UH, 2009, “Hepatitis B virus DNA levels and outcomes in chronic hepatitis B ”, Hepatology, 49,S72-S84. (SCI)
Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ*, 2009, “Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study”, J Natl Cancer Inst, 101, 1019-1027.
Wang CH, Chen CL, Hsiao CK, Chiang FT, Hsu LI, Chiou HY, Hsueh YM, Wu MM, Chen CJ*, 2009, “Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan”, Toxicol Appl Pharmacol, 239:320-324. (SCI)
Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ* , 2009, “Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a twenty-year follow-up study on 9622 Males without family history in Taiwan”, Cancer Epidemiol Biomarkers Prev, 18:1218-1226.
Chung CJ, Hsueh YM*, Bai CH, Huang YK, Huang YL, Yang MS, Chen CJ, 2009, “Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer”, Cancer Cause Control, 20:1653-1661. (SCI)
Kitchin KT, Del Razo LM, Chen CJ, Vahter M, 2009, “Preface: Spain arsenic meeting (editorial)”, Toxicol Appl Pharmacol, 239:127-129. (SCI)
Liao CM, Shen HH, Chen CL, Hsu LI, Lin TL, Chen SC, Chen CJ, 2009, “Risk assessment of arsenic-induced internal cancer at long-term low dose exposure”, J Hazard Mater, 165,652-663. (SCI)
Li WF, Sun CW, Cheng TJ, Chang KH, Chen CJ, Wang SL, 2009, “Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in southwestern Taiwan ”, Toxicol Appl Pharmacol, 236:246-253. (SCI)
Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ*, 2009, “Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study”, Liver Int, 30:423-429. (SCI) (IF: 4.5; SCI ranking: 20%)
Liao YT, Li WF, Chen CJ, Prineas RJ, Chen WJ, Zhang ZM, Sun CW, Wang SL, 2009, “Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality”, Toxicol Appl Pharmacol, 239:178-183. (SCI)
Huang YL, Hsueh YM*, Huang YK, Yip PK, Yang MH, Chen CJ, 2009, “Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan”, Sci Total Environ, 407(8), 2608-2614. (SCI)
Chien MH, Ku CC, Johansson G, Chen MW, Hsiao M, Su JL, Inoue H, Hua KT, Wei LH, Kuo ML, 2009, “Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.”, Carcinogenesis, Dec; 30(12), 2005-2013. Cite 43. (SCI)
Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, Lu PJ, 2009, “MicroRNA-330 (miR-330) induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation”, Oncogene, Sep 24;28(38):3360-3370. Cite 82. (SCI)
Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT, Lu PJ, 2009, “MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer”, Exp Cell Res, Sep 10;315(15):2529-38. Cite 90. (SCI)
Yeh CC, Deng YT, Sha DY, Hsiao M, Kuo MY, 2009, “Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression.”, Mol Cancer Ther, Sep; 8(9),2718-2725. Cite 21. (SCI)
Hsu PI, Hsieh HL, Lin LF, Chen HC, Lu PJ, Hsiao M*, 2009, “Loss of RUNX3 expression correlates with poor differentiation, nodal metastasis and dismal prognosis of gastric cancer”, Ann Surg Oncol, Jun;16(6):1686-94. Cite 33. (SCI)
Parad HJ, Chen HM, Lai TC, Huang JH, Liu RS, Hsiao M, Chen CH, Tsai DP, Hwu YK, 2009, “Biosensing, cytotoxicity and cellular uptake studies of surface modified gold nanorods”, J Phys Chem C, May; 113(18) 7574-7578. Cite 78. (SCI)
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M*, Huang HD, Tsou AP, 2009, “MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.”, Hepatology, May; 49(5), 1571-1582. Cite 410. (SCI)
KW Leung CH Tsai, M Hsiao, CJ Tseng, LP Ger, KH Lee, PJ Lu., 2009, “Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma”, Oncol Rep, Apr; 21(4):1097-1104. Cite 17. (SCI)
Chiang HT, Wang JL, Lu PJ, Huang HN, Lo WC, Tseng YC, Hsiao M*, Tseng CJ, 2009, “nNOS activation is involved in insulin mediated cardiovascular effects in the NTS of rats”, Neuroscience, Mar 17;159(2):727-34. Cite 17. (SCI)
Chan, Y.-H., Chiang, M.-F., Tsai, Y.-C., Su, S.-T., Chen M.-H., Hou, M.-S., and Lin, K.-I*, 2009, “Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in the conventional dendritic cell homeostatic development and function.”, Journal of Immunology, 183 (11), 7039-7046. (SCI)
Su, S.-T., Ying, H.-Y., Chiu, Y.-K., Lin, F.-R., Chen, M.-Y. and Lin, K.-I*, 2009, “Involvement of LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation”, MOLECULAR AND CELLULAR BIOLOGY, 29 (6), 1421-1431. (SCI)
Yang CJ, Liu YK, Liu CL, Shen CN, Kuo ML, Su CC, Tseng CP, Yen TC, Shen CR, 2009, “Inhibition of Acidic Mammalian Chitinase by RNA Interference Suppresses OVA-sensitized Allergic Asthma.”, Human gene therapy, 20(12),1597–1606. (SCI)
Yang YL, Liao WY, Liu WY, Liaw CC, Shen CN, Huang ZY, Wu SH, 2009, “Discovery of New Natural Products by Intact-Cell Mass Spectrometry and LC-SPE-NMR: Malbranpyrroles, Novel Polyketides from Thermophilic Fungus Malbranchea sulfurea.”, Chemistry-A European Journal, 15(43), 11573-11580. (SCI)
Huang YC, Hwang TL, Chang CS, Yang YL, Shen CN, Liao WY, Chen SC, Liaw CC, 2009, “Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.”, Journal of natural products, 72(7), 1273-1278. (SCI)
Huang YH, Chin CC, Ho HN, Chou CK, Shen CN, Kuo HC, Wu TJ, Wu YC, Hung YC, Chang CC, Ling TY, 2009, “Pluripotency of mouse spermatogonial stem cells maintained by IGF-1- dependent pathway.”, FASEB Journal, 23(7), 2076-2087. (SCI)
Yu, Alice Lin-Tsing
Lo TC, Barnhill LM, Kim Y, Nakae EA, Yu AL, Diccianni MB*, 2009, “Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.”, LEUKEMIA RESEARCH, 33(11), 1562-1566. (SCI)
Kuo MW, Wang SH, Chang JC, Chang CH, Huang LJ, Lin HH, Yu AL, Li WH, Yu J*, 2009, “A novel puf-A gene predicted from evolutionary analysis is involved in the development of eyes and primordial germ-cells.”, PLoS ONE, 4(3), e4980. (SCI)
Lee CH, Chou TC, Su TL, Yu J, Shao LE, Yu AL*, 2009, “BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug sensitive and drug resistant leukemia cells and solid tumors.”, Cancer Lett, 276(2), 204-211. (SCI)
Gilman AL*, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM, 2009, “Phase I Study of ch14.18 with GM-CSF and IL-2 in Children with Neuroblastoma Following Autologous Bone Marrow Transplant or Stem Cell Rescue A Report from the Children's Oncology Group.”, J Clin Oncol, 27(1), 85-91. (SCI)